Peter Brodbin serves as the Director of Medical Information Effectiveness at Pfizer, where he leverages his extensive experience in Medical Information to drive strategic initiatives that enhance the quality and accessibility of medical knowledge across the organization. In his current role, Peter focuses on optimizing...
Peter Brodbin serves as the Director of Medical Information Effectiveness at Pfizer, where he leverages his extensive experience in Medical Information to drive strategic initiatives that enhance the quality and accessibility of medical knowledge across the organization. In his current role, Peter focuses on optimizing global medical information (MI) operations through data analysis and analytics, ensuring that the information provided to healthcare professionals and patients is not only accurate but also relevant and timely. His leadership extends beyond Pfizer, as he actively participates in cross-industry associations, advocating for best practices and innovation in the field of medical information.
Peter’s expertise encompasses a wide range of skills, including operational effectiveness, compliance, and quality assurance, honed through numerous audits and inspections. He is adept at developing and implementing strategies that improve colleague engagement and communication, fostering a collaborative environment that enhances team performance. His proficiency in medical information systems and contact center operations allows him to streamline processes, ensuring that customer engagement is prioritized and that inquiries are addressed efficiently.
Key projects under Peter’s leadership have included the integration of advanced analytics to assess the impact of medical information on healthcare outcomes and the development of robust training programs aimed at enhancing employee engagement within the MI function. By focusing on these areas, Peter not only supports Pfizer's mission to deliver high-quality medical information but also contributes to the broader pharmaceutical industry’s commitment to transparency and patient safety. His dedication to excellence and compliance positions him as a pivotal figure in shaping the future of medical information effectiveness at Pfizer and beyond.
